Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced that it has reached an agreement with the Attorney General of Florida that settles the state’s opioid-related claims.
Under the terms of the settlement, Teva will pay Florida $177 million over 15 years. The Israeli pharmaceutical company will also provide Florida its recently launched generic opioid overdose treatment Narcan (naloxone hydrochloride nasal spray) valued at $84 million (wholesale acquisition cost) over 10 years.
RELATED ARTICLES
Teva said that the settlement is another critical step forward in getting life-saving treatments to people suffering from opioid addiction and stressed that the settlement agreement is not an admission of any liability or wrongdoing. Teva said that it would continue to defend itself in court in states where it has not reached terms of a settlement agreement.
In February, Teva reached a similar settlement with Texas, in which it will pay $150 million over 15 years and provide Narcan worth $75 million (wholesale acquisition cost) over 10 years. Last week Teva reached a settlement with Rhode Island in which it will pay $21 million over 13 years and $78.5 million in Narcan and other treatments over 10 years.
Published by Globes, Israel business news – en.globes.co.il – on March 30, 2022.
© Copyright of Globes Publisher Itonut (1983) Ltd., 2022.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
